Search Results

Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample.

• Authors : Capoor MN; Department of Bacterial Pathogenesis and Immunology, Rockefeller University, New York, New York, United States of America; MMF Systems, Inc., New York, New York, United States of America.

Subjects: Partial Thromboplastin Time* ; Prothrombin Time*; Adult

• Source: PloS one [PLoS One] 2015 Aug 11; Vol. 10 (8), pp. e0133317. Date of Electronic Publication: 2015 Aug 11 (Print Publication: 2015).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer.

• Authors : Shirts BH; Department of Pathology, University of Utah Medical Center, Salt Lake City, UT 84124, USA; Rodgers GM

Subjects: Partial Thromboplastin Time* ; Prothrombin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*blood

• Source: Thrombosis research [Thromb Res] 2012 Sep; Vol. 130 (3), pp. e134-8. Date of Electronic Publication: 2012 Apr 28.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited

Record details

Activated partial thromboplastin time and risk of future venous thromboembolism.

• Authors : Zakai NA; Department of Medicine, Brown University and Boston University, Providence, RI, USA.; Ohira T

Subjects: Partial Thromboplastin Time*; Venous Thromboembolism/Venous Thromboembolism/Venous Thromboembolism/*blood; Cohort Studies

• Source: The American journal of medicine [Am J Med] 2008 Mar; Vol. 121 (3), pp. 231-8.Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0267200 Publication Model: Print Cited Medium:

Record details

Evaluating a mobile application for improving clinical laboratory test ordering and diagnosis.

• Authors : Meyer AND; Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center and Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Thompson PJ

Subjects: Attitude of Health Personnel* ; Clinical Decision-Making* ; Clinical Laboratory Techniques*

• Source: Journal of the American Medical Informatics Association : JAMIA [J Am Med Inform Assoc] 2018 Jul 01; Vol. 25 (7), pp. 841-847.Publisher: Oxford University Press Country of Publication: England NLM ID: 9430800 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Comparison of five point-of-care prothrombin and activated partial thromboplastin time devices based on age of blood sample.

• Authors : Searles B; State University of New York Upstate Medical University, Department of Cardiovascular Perfusion, College of Health Professions, Syracuse 13210, USA. ; Nasrallah F

Subjects: Cardiopulmonary Bypass* ; Partial Thromboplastin Time* ; Point-of-Care Systems*

• Source: The journal of extra-corporeal technology [J Extra Corpor Technol] 2002 Sep; Vol. 34 (3), pp. 178-81.Publisher: EDP Sciences Country of Publication: United States NLM ID: 0267637 Publication Model: Print Cited Medium:

Record details

Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.

• Authors : Becker RC; Thrombosis Research Center, University of Massachusetts Medical School, Worcester 01655-1214, USA.; Cannon CP

Subjects: Partial Thromboplastin Time* ; Thrombolytic Therapy*; Angina, Unstable/Angina, Unstable/Angina, Unstable/*drug therapy

• Source: American heart journal [Am Heart J] 1996 Mar; Vol. 131 (3), pp. 421-33.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Print

Record details

Evaluation of prothrombin time and partial thromboplastin time.

• Authors : Lahoti C; Monmouth Medical Center, Long Branch, NJ 07740.; Rangwala AF

Subjects: Partial Thromboplastin Time* ; Prothrombin Time*; American Medical Association

• Source: New Jersey medicine : the journal of the Medical Society of New Jersey [N J Med] 1992 May; Vol. 89 (5), pp. 375-8.Publisher: Medical Society of New Jersey Country of Publication: United States NLM ID: 8511653 Publication Model: Print Cited

Record details

Laboratory Reagents (dc 021:2015 - 33690000-3 Various Medicinal Products, Nk 024:2023: 55981-activated Partial Thromboplastin Time Ivd, (in Vitro Diagnostics), Set, Analysis Of Clot Formation; 30593 -.

• Source: Mena Report. 2024.

Record details

Laboratory monitoring of heparin therapy--the effect of different salts of heparin on the activated partial thromboplastin time.

• Authors : Banez EI; Triplett DA; Koepke J

Subjects: Blood Coagulation Tests* ; Partial Thromboplastin Time*; Hematology/Hematology/Hematology/*methods

• Source: American journal of clinical pathology [Am J Clin Pathol] 1980 Oct; Vol. 74 (4 Suppl), pp. 569-74.Publisher: Oxford University Press Country of Publication: England NLM ID: 0370470 Publication Model: Print Cited Medium: Print ISSN: 0002-9173

Record details

Preoperative PTs, PTTs, cost-effectiveness, and health care reform. Radical changes that make good sense.

• Authors : Kitchens CS

Subjects: Partial Thromboplastin Time* ; Prothrombin Time*; Health Care Reform/Health Care Reform/Health Care Reform/*economics

• Source: Chest [Chest] 1994 Sep; Vol. 106 (3), pp. 661-2.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print

Record details